Out-licensing

Collagen-based biodegradable matrices for localized drug delivery More

Our client company has developed an innovative frozen lozenge technology designed to deliver pharmaceuticals and OTC products, which offers a new alternative administration method for paediatric and otherwise difficult to swallow therapeutics. More

A simple blood based assay to identify diabetic patients who are likely to develop or have early stage diabetic nephropathy has been developed at King's. This has the potential to be used regularly at diabetic clinics. More

Nanoparticles that exhibit high epithelial uptake and transepithelial transport More

This newly developed dose measuring technology comprises of a thin foil that dissolves readily in the mouth thereby administering the exact dosage of certain medications. More

Metformin Hydrochloride Tablets 750mg has dissolution profile of 10 hours and manufactured by hydrophilic matrix technology using cellulosic polymers. More

Development of a Polygenic Mouse Model for Juvenile Obesity More